Reversible Hair Loss in Lichen Planopilaris | Great Cases from the JDD
171661716617166
INTRODUCTION
Lichen planopilaris (LPP) is a cicatricial alopecia that presents with patchy or diffuse hair loss at the vertex or parietal scalp. Although there is no gold standard therapy, most interventions are immune modulating and aimed at reducing inflammation and terminating the scarring process to prevent further fibrosis.3 Even amongst patients who respond to therapy, hair loss at alopeci …
INTRODUCTION
Lichen planopilaris (LPP) is a cicatricial alopecia that presents with patchy or diffuse hair loss at the vertex or parietal scalp. Although there is no gold standard therapy, most interventions are immune modulating and aimed at reducing inflammation and terminating the scarring process to prevent further fibrosis.3 Even amongst patients who respond to therapy, hair loss at alopeci … Continue reading "Reversible Hair Loss in Lichen Planopilaris | Great Cases from the JDD"
Next Steps in Derm, in partnership with Skin of Color Update, interviewed Dr. Cheryl Burgess, medical director of the Center for Dermatology in Washington, D.C., and an assistant clinical professor of dermatology at Georgetown University, Washington, D.C. Dr. Burgess explains the filler complications that are more common in patients with skin of color, and the questions you should ask before you … 
INSIDER recently posted an article on so-called "Ozempic Face" and the steps taken to treat a gaunt face after rapid weight loss. How common is “Ozempic Face,” and what’s the best way to treat it? What cautions should dermatologists keep in mind when treating patients who have experienced rapid weight loss?
For expert advice, I reached out to Robyn Siperstein, MD, FAAD, a dermatologist … 
Next Steps in Derm, in partnership with Skin of Color Update, interviewed Dr. Heather Woolery-Lloyd, who is board certified in both dermatology and lifestyle medicine. Watch as she shares the six major pillars of lifestyle medicine, and which dermatologic conditions are shown to be influenced by lifestyle factors. You may change how you counsel your patients after watching this video!
F … 
The February issue of the Journal of Drugs in Dermatology (JDD) includes the perfect blend of original articles, case reports, and brief communications exploring topics such as efficacy and safety of 1% clascoterone cream in patients aged ≥12 years with acne vulgaris, dupilumab’s impact on atopic dermatitis among adolescent and adult patients, development and validation of a photonumeric scale … 